<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">38283209</PMID><DateRevised><Year>2024</Year><Month>01</Month><Day>31</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Print">1999-768X</ISSN><JournalIssue CitedMedium="Print"><Volume>38</Volume><Issue>6</Issue><PubDate><Year>2023</Year><Month>Nov</Month></PubDate></JournalIssue><Title>Oman medical journal</Title><ISOAbbreviation>Oman Med J</ISOAbbreviation></Journal><ArticleTitle>Persistence of Symptoms Following Hospitalization for COVID-19 in Oman: &#x2028;A Bidirectional Observational Study.</ArticleTitle><Pagination><StartPage>e570</StartPage><MedlinePgn>e570</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.5001/omj.2023.120</ELocationID><Abstract><AbstractText Label="OBJECTIVES" NlmCategory="UNASSIGNED">This study sought to assess the prevalence of persistent COVID-19-related symptoms in patients with mild, severe, and critical disease.</AbstractText><AbstractText Label="METHODS" NlmCategory="UNASSIGNED">We conducted a bidirectional cohort observational study that included all adult patients &#x2265; 18 years, admitted to Armed Forces Hospital, Muscat between July 2020 and June 2022, with COVID-19 infection and discharged alive. Patients were requested to attend outpatient clinic at weeks six and 12 post-discharge, where they filled out a questionnaire and underwent a chest X-ray. Additionally, blood tests were performed if necessary. Healthcare workers with mild infections were also requested to fill out a questionnaire about their initial symptoms, persistent symptoms, and comorbidities.</AbstractText><AbstractText Label="RESULTS" NlmCategory="UNASSIGNED">The study included 468 patients, comprising 261 hospitalized patients and 207 healthcare workers. On follow-up, 39.7% of patients presented with residual symptoms, such as cough, breathlessness, and joint pain. These symptoms were more common in patients with medical comorbidities, particularly hypertension, diabetes, and dyslipidemia. Notably, these symptoms were also observed in patients with mild disease. Post-COVID-19 pulmonary fibrosis was observed in 21 patients, mainly among those admitted to the intensive care unit or requiring prolonged hospitalization.</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="UNASSIGNED">This study highlights the persistence of symptoms and the prevalence of post-COVID-19 syndrome at two months post-discharge, especially among patients with severe and critical disease during the acute phase. Various predictors of post-COVID-19 syndrome were identified, including female gender, older age, presence of comorbidities, disease severity, and hypertension. Therefore, patients in these categories require thorough evaluation and long-term follow-up to manage residual symptoms.</AbstractText><CopyrightInformation>Copyright &#xa9; 2023, Oman Medical Journal.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Al Jahdhami</LastName><ForeName>Issa</ForeName><Initials>I</Initials><AffiliationInfo><Affiliation>Department of Medicine, Armed Forces Hospital, Muscat, Oman.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Arshad</LastName><ForeName>Husna</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Department of Medicine, Armed Forces Hospital, Muscat, Oman.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Omar</LastName><ForeName>Hiba</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Endemic Medicine and Hepatology Department, Faculty of Medicine, Cairo University, Cairo, Egypt.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bennji</LastName><ForeName>Sami M</ForeName><Initials>SM</Initials><AffiliationInfo><Affiliation>Sultan Qaboos Comprehensive Cancer Care and Research Centre, Muscat, Oman.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Al Nomani</LastName><ForeName>Khalid</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Department of Medicine, Armed Forces Hospital, Muscat, Oman.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Al Ghafri</LastName><ForeName>Manal</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Medicine, Armed Forces Hospital, Muscat, Oman.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Al Syabi</LastName><ForeName>Maryam</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Medicine, Armed Forces Hospital, Muscat, Oman.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Al Hinai</LastName><ForeName>Sumaya</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Medicine, Armed Forces Hospital, Muscat, Oman.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Al Mawali</LastName><ForeName>Adhra</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Quality Assurance and Planning, German University of Technology, Muscat, Oman.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>11</Month><Day>30</Day></ArticleDate></Article><MedlineJournalInfo><Country>Oman</Country><MedlineTA>Oman Med J</MedlineTA><NlmUniqueID>101526350</NlmUniqueID><ISSNLinking>1999-768X</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">COVID-19 Pandemic</Keyword><Keyword MajorTopicYN="N">Long COVID</Keyword><Keyword MajorTopicYN="N">Oman</Keyword><Keyword MajorTopicYN="N">Post-Acute COVID-19 Syndrome</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2023</Year><Month>3</Month><Day>31</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2023</Year><Month>7</Month><Day>2</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>1</Month><Day>29</Day><Hour>6</Hour><Minute>43</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>1</Month><Day>29</Day><Hour>6</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>1</Month><Day>29</Day><Hour>4</Hour><Minute>21</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2023</Year><Month>11</Month><Day>30</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">38283209</ArticleId><ArticleId IdType="pmc">PMC10822130</ArticleId><ArticleId IdType="doi">10.5001/omj.2023.120</ArticleId><ArticleId IdType="pii">OMJ-38-06-2300225</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Magkos F, Fabbrini E, Mohammed BS, Patterson BW, Klein S. Increased whole-body adiposity without a concomitant increase in liver fat is not associated with augmented metabolic dysfunction. Obesity (Silver Spring) 2010. Aug;18(8):1510-1515. 10.1038/oby.2010.90</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/oby.2010.90</ArticleId><ArticleId IdType="pmc">PMC3319734</ArticleId><ArticleId IdType="pubmed">20395947</ArticleId></ArticleIdList></Reference><Reference><Citation>Li Q, Guan X, Wu P, Wang X, Zhou L, Tong Y, et al. . Early transmission dynamics in Wuhan, China, of novel coronavirus-infected pneumonia. N Engl J Med 2020. Mar;382(13):1199-1207. 10.1056/NEJMoa2001316</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMoa2001316</ArticleId><ArticleId IdType="pmc">PMC7121484</ArticleId><ArticleId IdType="pubmed">31995857</ArticleId></ArticleIdList></Reference><Reference><Citation>Guan WJ, Ni ZY, Hu Y, Liang WH, Ou CQ, He JX, et al. China Medical Treatment Expert Group for Covid-19 . Clinical Characteristics of Coronavirus Disease 2019 in China. N Engl J Med 2020. Apr;382(18):1708-1720. 10.1056/NEJMoa2002032</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMoa2002032</ArticleId><ArticleId IdType="pmc">PMC7092819</ArticleId><ArticleId IdType="pubmed">32109013</ArticleId></ArticleIdList></Reference><Reference><Citation>Richardson S, Hirsch JS, Narasimhan M, Crawford JM, McGinn T, Davidson KW, et al. the Northwell COVID-19 Research Consortium . Presenting characteristics, comorbidities, and outcomes among 5700 patients hospitalized with COVID-19 in the New York City area. JAMA 2020. May;323(20):2052-2059. 10.1001/jama.2020.6775</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2020.6775</ArticleId><ArticleId IdType="pmc">PMC7177629</ArticleId><ArticleId IdType="pubmed">32320003</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang D, Hu B, Hu C, Zhu F, Liu X, Zhang J, et al. . Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus-infected pneumonia in Wuhan, China. JAMA 2020. Mar;323(11):1061-1069. 10.1001/jama.2020.1585</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2020.1585</ArticleId><ArticleId IdType="pmc">PMC7042881</ArticleId><ArticleId IdType="pubmed">32031570</ArticleId></ArticleIdList></Reference><Reference><Citation>Arentz M, Yim E, Klaff L, Lokhandwala S, Riedo FX, Chong M, et al. . Characteristics and outcomes of 21 critically Ill patients with COVID-19 in Washington State. JAMA 2020. Apr;323(16):1612-1614. 10.1001/jama.2020.4326</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2020.4326</ArticleId><ArticleId IdType="pmc">PMC7082763</ArticleId><ArticleId IdType="pubmed">32191259</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang Y, Xiao M, Zhang S, Xia P, Cao W, Jiang W, et al. . Coagulopathy and antiphospholipid antibodies in patients with Covid-19. N Engl J Med 2020. Apr;382(17):e38. 10.1056/NEJMc2007575</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMc2007575</ArticleId><ArticleId IdType="pmc">PMC7161262</ArticleId><ArticleId IdType="pubmed">32268022</ArticleId></ArticleIdList></Reference><Reference><Citation>Mao L, Jin H, Wang M, Hu Y, Chen S, He Q, et al. . Neurologic manifestations of hospitalized patients with coronavirus disease 2019 in Wuhan, China. JAMA Neurol 2020. Jun;77(6):683-690. 10.1001/jamaneurol.2020.1127</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamaneurol.2020.1127</ArticleId><ArticleId IdType="pmc">PMC7149362</ArticleId><ArticleId IdType="pubmed">32275288</ArticleId></ArticleIdList></Reference><Reference><Citation>Fern&#xe1;ndez-de-Las-Pe&#xf1;as C, Palacios-Ce&#xf1;a D, G&#xf3;mez-Mayordomo V, Florencio LL, Cuadrado ML, Plaza-Manzano G, et al. . Prevalence of post-COVID-19 symptoms in hospitalized and non-hospitalized COVID-19 survivors: A systematic review and meta-analysis. Eur J Intern Med 2021. Oct;92:55-70. 10.1016/j.ejim.2021.06.009</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ejim.2021.06.009</ArticleId><ArticleId IdType="pmc">PMC8206636</ArticleId><ArticleId IdType="pubmed">34167876</ArticleId></ArticleIdList></Reference><Reference><Citation>Sudre CH, Murray B, Varsavsky T, Graham MS, Penfold RS, Bowyer RC, et al. . Attributes and predictors of long COVID. Nat Med 2021. Apr;27(4):626-631. 10.1038/s41591-021-01292-y</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-021-01292-y</ArticleId><ArticleId IdType="pmc">PMC7611399</ArticleId><ArticleId IdType="pubmed">33692530</ArticleId></ArticleIdList></Reference><Reference><Citation>Lopez-Leon S, Wegman-Ostrosky T, Perelman C, Sepulveda R, Rebolledo PA, Cuapio A, et al. . More than 50 long-term effects of COVID-19: a systematic review and meta-analysis. Sci Rep 2021. Aug;11(1):16144. 10.1038/s41598-021-95565-8</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-021-95565-8</ArticleId><ArticleId IdType="pmc">PMC8352980</ArticleId><ArticleId IdType="pubmed">34373540</ArticleId></ArticleIdList></Reference><Reference><Citation>World Health Organization. A clinical case definition of post COVID-19 condition by a Delphi consensus, 6 October 2021. 2021 [cited 2023 June 30]. Available from: https://www.who.int/publications/i/item/WHO-2019-nCoV-Post_COVID-19_condition-Clinical_case_definition-2021.1.</Citation></Reference><Reference><Citation>Naeije R, Caravita S. Phenotyping long COVID. Eur Respir J 2021. Aug;58(2):2101763. 10.1183/13993003.01763-2021</Citation><ArticleIdList><ArticleId IdType="doi">10.1183/13993003.01763-2021</ArticleId><ArticleId IdType="pmc">PMC8287735</ArticleId><ArticleId IdType="pubmed">34244323</ArticleId></ArticleIdList></Reference><Reference><Citation>Heightman M, Prashar J, Hillman TE, Marks M, Livingston R, Ridsdale HA, et al. . Post-COVID-19 assessment in a specialist clinical service: a 12-month, single-centre, prospective study in 1325 individuals. BMJ Open Respir Res 2021. Nov;8(1):e001041. 10.1136/bmjresp-2021-001041</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmjresp-2021-001041</ArticleId><ArticleId IdType="pmc">PMC8587466</ArticleId><ArticleId IdType="pubmed">34764200</ArticleId></ArticleIdList></Reference><Reference><Citation>Shoucri SM, Purpura L, DeLaurentis C, Adan MA, Theodore DA, Irace AL, et al. . Characterising the long-term clinical outcomes of 1190 hospitalised patients with COVID-19 in New York City: a retrospective case series. BMJ Open 2021. Jun;11(6):e049488. 10.1136/bmjopen-2021-049488</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmjopen-2021-049488</ArticleId><ArticleId IdType="pmc">PMC8182750</ArticleId><ArticleId IdType="pubmed">34083350</ArticleId></ArticleIdList></Reference><Reference><Citation>Nasserie T, Hittle M, Goodman SN. Assessment of the frequency and variety of persistent symptoms among patients with COVID-19: a systematic review. JAMA Netw Open 2021. May;4(5):e2111417. 10.1001/jamanetworkopen.2021.11417</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamanetworkopen.2021.11417</ArticleId><ArticleId IdType="pmc">PMC8155823</ArticleId><ArticleId IdType="pubmed">34037731</ArticleId></ArticleIdList></Reference><Reference><Citation>See&#xdf;le J, Waterboer T, Hippchen T, Simon J, Kirchner M, Lim A, et al. . Persistent symptoms in adult patients 1 year after coronavirus disease 2019 (COVID-19): a prospective cohort study. Clin Infect Dis 2022. Apr;74(7):1191-1198. 10.1093/cid/ciab611</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/cid/ciab611</ArticleId><ArticleId IdType="pmc">PMC8394862</ArticleId><ArticleId IdType="pubmed">34223884</ArticleId></ArticleIdList></Reference><Reference><Citation>Al-Jahdhami I, Al-Mawali A, Bennji SM, Bennji SM, Khalid Al-naamani1 . Respiratory Complications after COVID-19. Oman Med J 2022. Jan;37(1):e343. 10.5001/omj.2022.52</Citation><ArticleIdList><ArticleId IdType="doi">10.5001/omj.2022.52</ArticleId><ArticleId IdType="pmc">PMC8907756</ArticleId><ArticleId IdType="pubmed">35282425</ArticleId></ArticleIdList></Reference><Reference><Citation>World Health Organization. Therapeutics and COVID-19: living guideline. 10th ed; 2022.</Citation><ArticleIdList><ArticleId IdType="pubmed">35917393</ArticleId></ArticleIdList></Reference><Reference><Citation>Galal I, Hussein AA, Amin MT, Saad MM, Zayan HE, Abdelsayed MZ, et al. . Determinants of persistent post-COVID-19 symptoms: value of a novel COVID-19 symptom score. Egypt J Bronchol 2021;15(1):10 .10.1186/s43168-020-00049-4</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s43168-020-00049-4</ArticleId></ArticleIdList></Reference><Reference><Citation>Nalbandian A, Sehgal K, Gupta A, Madhavan MV, McGroder C, Stevens JS, et al. . Post-acute COVID-19 syndrome. Nat Med 2021. Apr;27(4):601-615. 10.1038/s41591-021-01283-z</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-021-01283-z</ArticleId><ArticleId IdType="pmc">PMC8893149</ArticleId><ArticleId IdType="pubmed">33753937</ArticleId></ArticleIdList></Reference><Reference><Citation>Alghamdi SA, Alfares MA, Alsulami RA, Alghamdi AF, Almalawi AM, Alghamdi MS, et al. . Post-COVID-19 syndrome: incidence, risk factor, and the most common persisting symptoms. Cureus 2022. Nov;14(11):e32058. 10.7759/cureus.32058</Citation><ArticleIdList><ArticleId IdType="doi">10.7759/cureus.32058</ArticleId><ArticleId IdType="pmc">PMC9802640</ArticleId><ArticleId IdType="pubmed">36600841</ArticleId></ArticleIdList></Reference><Reference><Citation>AlRadini FA, Alamri F, Aljahany MS, Almuzaini Y, Alsofayan Y, Khan A, et al. . Post-acute COVID-19 condition in Saudi Arabia: A national representative study. J Infect Public Health 2022. May;15(5):526-532. 10.1016/j.jiph.2022.03.013</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jiph.2022.03.013</ArticleId><ArticleId IdType="pmc">PMC8949843</ArticleId><ArticleId IdType="pubmed">35429791</ArticleId></ArticleIdList></Reference><Reference><Citation>Munblit D, Bobkova P, Spiridonova E, Shikhaleva A, Gamirova A, Blyuss O, et al. Sechenov StopCOVID Research Team . Incidence and risk factors for persistent symptoms in adults previously hospitalized for COVID-19. Clin Exp Allergy 2021. Sep;51(9):1107-1120. 10.1111/cea.13997</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/cea.13997</ArticleId><ArticleId IdType="pmc">PMC8444748</ArticleId><ArticleId IdType="pubmed">34351016</ArticleId></ArticleIdList></Reference><Reference><Citation>Peghin M, Palese A, Venturini M, De Martino M, Gerussi V, Graziano E, et al. . Post-COVID-19 symptoms 6&#xa0;months after acute infection among hospitalized and non-hospitalized patients. Clin Microbiol Infect 2021. Oct;27(10):1507-1513. 10.1016/j.cmi.2021.05.033</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cmi.2021.05.033</ArticleId><ArticleId IdType="pmc">PMC8180450</ArticleId><ArticleId IdType="pubmed">34111579</ArticleId></ArticleIdList></Reference><Reference><Citation>Logue JK, Franko NM, McCulloch DJ, McDonald D, Magedson A, Wolf CR, et al. . Sequelae in adults at 6 months after COVID-19 infection. JAMA Netw Open 2021. Feb;4(2):e210830. 10.1001/jamanetworkopen.2021.0830</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamanetworkopen.2021.0830</ArticleId><ArticleId IdType="pmc">PMC7896197</ArticleId><ArticleId IdType="pubmed">33606031</ArticleId></ArticleIdList></Reference><Reference><Citation>Davis HE, Assaf GS, McCorkell L, Wei H, Low RJ, Re&#x2019;em Y, et al. . Characterizing long COVID in an international cohort: 7 months of symptoms and their impact. EClinicalMedicine 2021. Aug;38:101019. 10.1016/j.eclinm.2021.101019</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.eclinm.2021.101019</ArticleId><ArticleId IdType="pmc">PMC8280690</ArticleId><ArticleId IdType="pubmed">34308300</ArticleId></ArticleIdList></Reference><Reference><Citation>Tleyjeh IM, Saddik B, AlSwaidan N, AlAnazi A, Ramakrishnan RK, Alhazmi D, et al. . Prevalence and predictors of Post-Acute COVID-19 Syndrome (PACS) after hospital discharge: A cohort study with 4 months median follow-up. PLoS One 2021. Dec;16(12):e0260568. 10.1371/journal.pone.0260568</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0260568</ArticleId><ArticleId IdType="pmc">PMC8651136</ArticleId><ArticleId IdType="pubmed">34874962</ArticleId></ArticleIdList></Reference><Reference><Citation>Senjam S, Balhara YP, Kumar P, Nichal N, Manna S, Madan K, et al. . Assessment of post COVID-19 health problems and its determinants in North India: a descriptive cross-sectional study. SSRN Electron J 2021. .10.2139/ssrn.3937558</Citation><ArticleIdList><ArticleId IdType="doi">10.2139/ssrn.3937558</ArticleId></ArticleIdList></Reference><Reference><Citation>Praschan N, Josephy-Hernandez S, Kim DD, Kritzer MD, Mukerji S, Newhouse A, et al. . Implications of COVID-19 sequelae for health-care personnel. Lancet Respir Med 2021. Mar;9(3):230-231. 10.1016/S2213-2600(20)30575-0</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2213-2600(20)30575-0</ArticleId><ArticleId IdType="pmc">PMC7834418</ArticleId><ArticleId IdType="pubmed">33444540</ArticleId></ArticleIdList></Reference><Reference><Citation>Aul DR, Gates DJ, Draper DA, Dunleavy DA, Ruickbie DS, Meredith DH, et al. . Complications after discharge with COVID-19 infection and risk factors associated with development of post-COVID pulmonary fibrosis. Respir Med 2021. Nov;188:106602. 10.1016/j.rmed.2021.106602</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.rmed.2021.106602</ArticleId><ArticleId IdType="pmc">PMC8425673</ArticleId><ArticleId IdType="pubmed">34536697</ArticleId></ArticleIdList></Reference><Reference><Citation>Ali RM, Ghonimy MB. Post-COVID-19 pneumonia lung fibrosis: a worrisome sequelae in surviving patients. Egypt J Radiol Nucl Med 2021;52(1):101 .10.1186/s43055-021-00484-3</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s43055-021-00484-3</ArticleId></ArticleIdList></Reference><Reference><Citation>Hama Amin BJ, Kakamad FH, Ahmed GS, Ahmed SF, Abdulla BA, Mohammed SH, et al. . Post COVID-19 pulmonary fibrosis; a meta-analysis study. Ann Med Surg (Lond) 2022. May;77:103590. 10.1016/j.amsu.2022.103590</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.amsu.2022.103590</ArticleId><ArticleId IdType="pmc">PMC8983072</ArticleId><ArticleId IdType="pubmed">35411216</ArticleId></ArticleIdList></Reference><Reference><Citation>Mandal S, Barnett J, Brill SE, Brown JS, Denneny EK, Hare SS, et al. ARC Study Group . &#x2018;Long-COVID&#x2019;: a cross-sectional study of persisting symptoms, biomarker and imaging abnormalities following hospitalisation for COVID-19. Thorax 2021. Apr;76(4):396-398. 10.1136/thoraxjnl-2020-215818</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/thoraxjnl-2020-215818</ArticleId><ArticleId IdType="pmc">PMC7615158</ArticleId><ArticleId IdType="pubmed">33172844</ArticleId></ArticleIdList></Reference><Reference><Citation>Varghese J, Sandmann S, Ochs K, Schrempf IM, Fr&#xf6;mmel C, Dugas M, et al. . Persistent symptoms and lab abnormalities in patients who recovered from COVID-19. Sci Rep 2021. Jun;11(1):12775. 10.1038/s41598-021-91270-8</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-021-91270-8</ArticleId><ArticleId IdType="pmc">PMC8211641</ArticleId><ArticleId IdType="pubmed">34140539</ArticleId></ArticleIdList></Reference><Reference><Citation>Sathish T, Kapoor N, Cao Y, Tapp RJ, Zimmet P. Proportion of newly diagnosed diabetes in COVID-19 patients: A systematic review and meta-analysis. Diabetes Obes Metab 2021. Mar;23(3):870-874. 10.1111/dom.14269</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/dom.14269</ArticleId><ArticleId IdType="pmc">PMC7753574</ArticleId><ArticleId IdType="pubmed">33245182</ArticleId></ArticleIdList></Reference><Reference><Citation>Garout MA, Saleh SA, Adly HM, Abdulkhaliq AA, Khafagy AA, Abdeltawab MR, et al. . Post-COVID-19 syndrome: assessment of short- and long-term post-recovery symptoms in recovered cases in Saudi Arabia. Infection 2022. Dec;50(6):1431-1439. 10.1007/s15010-022-01788-w</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s15010-022-01788-w</ArticleId><ArticleId IdType="pmc">PMC8924350</ArticleId><ArticleId IdType="pubmed">35294728</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>